expression of CMP-NeuAc:Galβ1,4GlcNAc α2,6-sialyltransferase (ST6Gal I) is induced as part of the acute phase response in mammals by mechanisms that remain poorly understood. Previous work suggests that murine liver ST6Gal I mRNA contains an additional and novel region that is not found on ST6Gal I mRNA from human HepG2 hepatoma cells and from rat liver. This novel region, residing 5′ of the common Exon I sequence, is encoded by a discrete upstream exon, Exon H. Here we provide evidence that the Exon H-containing transcript is the murine counterpart of the human and rat ST6Gal I mRNAs transcribed from the hepatic-specific promoter, P1. Exon H-containing ST6Gal I mRNA is expressed in all three mice strains examined: balb/c, C57B46, and 129Sv. Furthermore, murine RNA tissue survey indicates that presence of Exon H-containing transcripts is restricted to the liver. When mice are subjected to subcutaneous injection of turpentine to elicit the hepatic acute phase response, greater than 4-fold elevation in liver ST6Gal I mRNA was observed. Consistent with the view that Exon H-containing transcripts is regulated by the murine P1 promoter, 5′-RACE analysis indicates that the majority of these transcripts contains the Exon H sequence. This is consistent with the view that Exon H-containing transcripts are regulated by the murine P1 region. To assess the mechanism of ST6Gal I response in the hepatic acute phase reaction, mice harboring lesions in both alleles of the IL-6 gene were examined. IL-6(-/-) animals expressed normal levels of ST6Gal I mRNA in liver, with Exon H-containing transcripts remaining the predominant mRNA isoform. However, hepatic ST6Gal I is not elevated upon turpentine injection in the IL-6(-/-) animals. These results indicate that ST6Gal I induction in mouse liver during the acute phase reaction is mediated predominantly by the IL-6 pathway, and results in the induction of the Exon H-containing class of ST6Gal I mRNA that is specific to the liver.
Introduction
The hepatic acute phase response (APR) is one of the earliest phenomena to acute systemic or local injury, trauma, or infection as part of the homeostatic process known as inflammation. Elevation of liver and serum ST6Gal I (ST6N, β-galactoside α2,6-sialyltransferase) is one component of APR that include the induction of a subset of serum proteins, collectively known as the acute phase proteins (APP) (Jamieson et al., 1992) . The acute phase response can be experimentally elicited by subcutaneous injection of turpentine, which causes the formation of sterile abscesses leading to peripheral tissue damage (Baumann and Gauldie, 1994) . Turpentine injection acts primarily via the production cytokines IL-1β and IL-6 (Won et al., 1993) . However, unlike intraperitoneal injection of bacterial endotoxin (LPS) which reproduces systemic inflammation, turpentine does not induce TNF-α production (Beutler et al., 1985; Cooper et al., 1994) . Current theory suggests that LPS and turpentine inflammation is mediated by separate overlapping cytokine pathways. This is demonstrated by the absolute requirement of both IL-1β and IL-6 in turpentine-elicited APR, but not in the LPS reaction Fattori et al., 1994; Kopf et al., 1994; Fantuzzi et al., 1996; Horai et al., 1998) . Both modes of APR induction lead to the induction of corticosteroid hormones via the hypothalamic-pituitary-adrenal axis (HPA). Corticosteroids participate in the induction of most APP and are frequently for optimal stimulation.
Hepatic acute phase proteins are normally divided into one of two classes depending on their response to different cytokines (Baumann and Gauldie, 1990) . Class 1 APP is induced by IL-1 and TNF-α. IL-6 can also act to induce Class 1 APPs in a synergistic manner. Class 2 APPs are induced by IL-6 but TNF-α/IL-1 independent (or repressive). Furthermore, APP regulation by cytokines can be either positive (e.g., α1-acidglycoprotein) or negative (e.g., transferrin). Early work with primary rat hepatocyte cultures demonstrated that both cellular and secreted ST6Gal I can be upregulated by exposure of cells to glucocorticoid or to IL-6, but not interleukin-1 (IL-1) (Woloski et al., 1986) .
ST6Gal I is a type II Golgi-bound glycosyltransferase responsible for the attachment of sialic acid residues in a α2,6 linkage to the Galβ1,4GlcNAc termini of N-linked glycans common to many serum and cell surface glycoproteins. Consequently, while ST6Gal I is highly expressed in mammalian liver, it is also expressed in most other tissues (O'Hanlon et al., 1989; Paulson et al., 1989) A soluble form of ST6Gal I is secreted into the serum after proteolytic release of the catalytic domain from the N-terminus and membrane-spanning tether (Weinstein et al., 1987; Colley et al., 1989) .
A single gene, SIAT1, residing in chromosome 3 (q21-28), encodes human ST6Gal I (Wang et al., 1993) . The murine homologue, Siat1, maps to chromosome 16 (Kalcheva et al., 1997) . Collectively data from human and rat demonstrated that ST6Gal I transcription is regulated by multiple and physically distinct promoter regions. Differential utilization of these promoter regions forms the basis of differential ST6Gal I expression between tissues and results in mRNAs differing only in the 5′-UT regions (Wang et al., 1990a (Wang et al., , 1993 Lo and Lau, 1996) .
In human HepG2 hepatoma cells and in rat liver, ST6Gal I mRNA is transcriptionally initiated by a promoter residing immediately 5′ of Exon I (Wang et al., 1990b; Shah et al., 1992; Lo and Lau, 1996) . The expression of this promoter, P1, is restricted to liver and transiently in the small intestinal epithelium of new born animals (Vertino-Bell et al., 1994) .
Recently, our laboratory reported that murine liver expressed a ST6Gal I mRNA form containing a significant structural divergence from the human and rat hepatic forms. The murine ST6Gal I mRNA from liver incorporates an additional region, Exon H, residing 5′ of Exon I (Hu et al., 1997) . No evidence for transcriptional initiation at Exon I was found. In this report, we provide evidence that the Exon H-containing form is the murine homologue to the previously documented hepatic ST6Gal I mRNA forms in human and in rat. We demonstrate that increased hepatic ST6Gal I in mouse is specifically due to elevation of the Exon H-containing mRNA form. It follows that the P1-regulatory region is displaced in the mouse to reside 5′ of Exon H. Further, we demonstrate that IL-6 is the main controlling factor involved in the in vivo inflammatory increase of liver ST6Gal I.
Results

Exon H-containing ST6Gal I mRNA is not expressed in human liver
Early work demonstrated that a liver-specific promoter mediates transcription of ST6Gal I gene in hepatic tissues. The liverspecific promoter, P1, resides immediately 5′ of Exon I in rat (Wang et al., 1990a,b) . Likewise, ST6Gal I transcription also initiates at Exon I in human HepG2 cells (Shah et al., 1992; Wang et al., 1993) . Recently, our laboratory demonstrated that ST6Gal I mRNA from the liver of strain 129SvTer mouse contains an additional exon, Exon H, not present in human HepG2 or rat hepatic transcripts (Hu et al., 1997) . This observation suggests an essential species divergence of the murine ST6Gal I gene from the human and rat counterparts. Figure 1 is a schematic summarizing the ST6Gal I gene.
In order to assess that the mRNA obtained from HepG2 cells correctly represents that ST6Gal I mRNA form expressed in vivo in human liver, and that human liver ST6Gal I transcripts lack Exon H, 5′-RACE analysis of ST6Gal I transcripts were performed. Figure 2A is a agarose analysis of the 5′-RACE product as visualized by ethidium bromide. 5′-RACE of HepG2 ( Figure 2A , lane 3) resulted in products identical to those , and human liver RNA, after cDNA synthesis, was subjected to 5′-RACE amplification using AP1 (marathon adapter, sense) and md11 (mouse exon I, antisense) or md15 (human exon I, antisense) primers. Fragments were then run on a 3.0% agarose gel (0.5 µg/ml ethidium bromide), Southern blotted overnight, and then hybridized with a 160 bp PCR exon H probe. (A) 5′-RACE products run on agarose gel. Lane 1, negative control; lane 2, mouse liver (Balb/c); lane 3, HepG2; lanes 4 and 5, human liver. (B) Exon H probe hybridizes only to mouse 5′-RACE products. Lane 1, negative control; lane 2, mouse liver (Balb/c); lane 3, HepG2; lanes 4 and 5, human liver. generated from human liver ( Figure 2A , lanes 4 and 5). Arrow B points to the expected size of a PCR product that contains only Exon I sequence. Arrow C points to nonspecific products whose intensity varies from one reaction to the next. This smaller sized PCR product is target-independent since it is also present in the control reaction that does not contain cDNA (Lane 1). 5′-RACE products from HepG2 cells or from human liver do not hybridize to a probe against murine Exon H sequence ( Figure 2B ). In contrast, when mouse (balb/c) liver RNA was subjected to parallel 5′-RACE analysis, the resultant 270 bp product is consistent with the presence of the additional upstream Exon H sequence ( 
Exon H-containing ST6Gal I mRNA is universally expressed in murine liver
5′-RACE analysis of ST6Gal I transcripts was performed on a number of strains of Mus domesticus in order to assess the universality of Exon H. The result of this analysis is summarized in Figure 3 . Among the strains examined, an outbred (C57B46 -129Sv) containing homozygous lesion to the IL-6 locus (lane 1), wt C57B46 (lane 2), wt balb/c (lane 3), and wt 129Sv (lane 4), 5′-RACE analysis for liver ST6Gal I transcripts resulted in similar products as visualized by ethidium bromide ( Figure 3A) . Arrow shows the predicted sized band for transcripts containing the upstream Exon H sequence. When probed for the presence of Exon H sequence, all hybridized positively ( Figure 3B ). The 5′-RACE products were cloned and sequence analyzed to confirm Exon H-containing transcripts to be the predominant ST6Gal I mRNA isoform in these samples. Mouse liver from several strains of Mus domesticus were subject to 5′-RACE analysis using AP1 (marathon adapter, sense) and md11 (mouse exon I, antisense) primers. Fragments were then run on a 3.0% agarose gel (0.5 µg/ml ethidium bromide), Southern blotted overnight, and then hybridized with a 160 bp PCR exon H probe. A, 5′-RACE products run on agarose gel. Lane 1, C57Bl/6-129sv IL-6 "knockout"; lane 2, wild type C57Bl/6; lane 3, wild type Balb/c; lane 4, wild type 129sv. B, Exon H probe hybridizes to all strains. Lane 1, C57Bl/6-129sv IL-6 "knockout"; lane 2, wild type C57Bl/6; lane 3, wild type Balb/c; lane 4, wild type 129sv. Black arrows indicate the marathon adapter: exon H-exon I, 300-350 bp band.
Exon H-containing mRNA is the murine equivalent of human and rat hepatic ST6Gal I mRNA
Previous data demonstrated that promoter P1, residing adjacent to Exon I, regulates the expression of ST6Gal I gene expression in rat and human liver cells. In human and rat, expression of P1-regulated mRNA is restricted to liver and transiently in the newborn small intestine epithelium. Figure 4 is an RNA blot probed for the level of ST6Gal I mRNA in various murine tissues. The absolute level of ST6Gal I mRNA, visualized with a probe toward the coding region and is shared among all known forms of ST6Gal I mRNA, is shown in Figure 4A . When the blot was stripped of probe and rehybridized against Exon H ( Figure 4B ), it is clear that Exon H-containing transcripts are restricted to the liver. This observation is consistent with the view that Exon H-containing mRNA is the murine equivalent of the human and hepatic ST6Gal I mRNA. Furthermore, the current data suggests that the murine P1 promoter is displaced upstream and remote from Exon I.
Hepatic induction of ST6Gal I in the acute phase response is mediated by IL-6
The hepatic acute response is paralleled by a increase of hepatic ST6Gal I expression. The hepatic acute phase response is mediated by one of two major pathways, the IL-6 and the TNF-α pathways. In order to assess the participation of IL-6, a mediator of hepatic acute phase response, in murine liver ST6Gal I expression, mice were treated with a single subcutaneous injection of turpentine to elicit the acute phase response. Wt mice and mice containing a homozygous lesion for IL-6 were examined. Pairs of mice were sacrificed at time points up to 24 h after injection. As seen in Figure  5 , wt mice responded by ∼4-fold elevation of hepatic ST6Gal I mRNA by 24 h. Turpentine injection also resulted in the expected hepatic elevation of mRNA for α1-acid glycoprotein, a wellstudied acute phase reactant (data not shown). In contrast, the level of hepatic ST6Gal I mRNA remained unchanged in animals unable to elaborate IL-6. Representative RNA blots of 0 and 24 h post turpentine inject are shown in Figure 6 and clearly demonstrates the lack of hepatic ST6Gal I response in IL-6(-/-) animals. Neither wt or IL-6(-/-) animals showed any significant changes in liver CMP-NeuAc:Galβ1,3GalNAc α2,3sialyltransferase (ST3GalI), CMP-NeuAc:Galβ1,3(4)GlcNAc α2,3sialyltransferase (ST3Gal-III), or CMP-NeuAc:Galβ1,3GalNAc/Galβ1,3(4)GlcNAc α2, 3sialyltransferase (ST3GalIV) mRNA expression after turpentine injection (data not shown). mRNA for a fourth α2,3sialyltransferase, ST3GalII, remains below detection levels in our blot assays.
In another experiment wt mice were injected with a subcutaneous dose of LPS, an irritant known to elicit the inflammatory response via a TNG-α dependent but IL-6 independent pathway (Beutler et al., 1985) . As seen in Figure 6 , hepatic ST6Gal I mRNA levels remained unchanged 24 h after LPS injection.
Hepatic ST6Gal I induction is mediated by the P1 promoter
In order to ascertain the ST6Gal I mRNA isoform that is elevated in the hepatic inflammatory response, 5′-RACE analysis was performed on liver from wt and IL-6(-/-) animals after subcutaneous injection of turpentine. The results are summarized in Figure 7 . For both wt and IL-6(-/-) samples, the overwhelmingly predominant 5′-RACE product as visualized by ethidium bromide is the 350 bp band consistent with the presence of Exon H sequence ( Figure 7A ). These observations are also consistent with our Northern blot analysis that Exon H-positive transcripts are elevated in the liver of turpentine-treated wt animals (data not shown). Furthermore, this band hybridizes positively for Exon H probe (data not shown). The 350 bp 5′-RACE product was isolated, cloned, and sequence analyzed. Sixteen clones were analyzed. All 16 contain Exon H region 5′ of Exon I as expected (data not shown).
Discussion
This study serves to confirm the observation that a significant species divergence exists between the ST6Gal I structural gene in . Liver ST6Gal I induction, in response to turpentine injection, is IL-6 dependent. Turpentine was injected subcutaneously into wt and IL-6 "knockout" mice pairs in order to elicit ST6Gal I induction in liver. Liver RNA was then extracted at various time points. The exon II 0.75 kb genomic probe was used to quantitate ST6Gal I mRNA levels, and the TPI probe used for background mRNA levels. Results were then standardized using exon II/TPI ratio. The data, plotted above, show that 24 h postturpentine injection, wt ST6Gal I mRNA has increased by more than 4-fold, while the same transcripts have not left their basal levels in the IL-6 deficient mice. Fig. 6 . Liver ST6Gal I is IL-6 sensitive, IL-1β/TNF-α insensitive. Liver ST6Gal I does not show the same 4-fold induction 24 h after subcutaneous lipopolysaccharide (LPS) injection as it does with turpentine. The former elicits the production of IL-1β and TNF-α, while the latter elicits IL-1β and IL-6 cytokine synthesis.
mouse from the previously analyzed human and rat counterparts. In mouse, the P1 promoter regulatory region is displaced significantly upstream and removed from its proximity to Exon I. This results in the incorporation of an additional sequence, encoded by Exon H, 5′ of Exon I sequence in murine hepatic Fig. 7 . 5′-RACE analysis for hepatic ST6Gal I mRNA isoforms in turpentine-injected wt and IL-6(-/-) mice. Liver was harvested from wt and IL-6(-/-) mice 24 h after subcutaneous injection with turpentine. RNA prepared from the livers were subjected to 5′-RACE amplification using AP1 (marathon adapter, sense) and md11(mouse exon I, antisense). The 5′-RACE products were analyzed on a 3.0% agarose gel (0.5 µg/ml ethidium bromide. The black arrow indicate Exon H positive region that is at the correct molecular weight for the P1 5′-UT region Exon H-Exon I (300-350 bp, inclusive of 50 bp marathon adapter).
ST6Gal I transcripts. Several lines of observation support the contention that Exon H-containing transcripts represent the murine equivalent of earlier documented human and rat liver ST6Gal I mRNAs. First, Exon H expression, as shown by a multiple murine tissue blot, is restricted to liver. Second, the hepatic inflammatory response elicited by turpentine results in accumulation of Exon H-containing ST6Gal I mRNAs. Third, Exon H-containing mRNA is the principle transcript in unstimulated and turpentine-injected wt mice. This study also provides data to substantiate the widely held notion that the ST6Gal I mRNA form from HepG2, a human hepatoma cell line, is representative of the form expressed in human liver in vivo.
This study also demonstrates the major role for IL-6 in the hepatic induction of ST6Gal I during turpentine-elicited inflammation in mice. Further, liver ST6Gal I can be classified as Class 2 positive acute phase protein based on three observations. First, it is induced by turpentine, which promotes production of IL-6 and IL1β. Second, ST6Gal I is not induced by turpentine in IL-6 deficient animals. Third, mouse liver ST6Gal I is not induced using lipopolysaccharide (LPS) injection after 24 h, which stimulates the production of TNF-α and IL-1β. However, it must be noted that we observed a small but significant elevation of hepatic ST6Gal I with LPS after 48 h. This elevation is consistent with the ability of IL-1β and TNF-α to elicit IL-6 as part of the secondary cytokine wave. These observations categorize ST6Gal I in the same group as other hepatic phase proteins such as α1-antitrypsin, rat α2-macroglobulin, and human haptoglobin, all of which are IL-6 sensitive, IL-1β/TNF-α insensitive (or repressive).
In conclusion, this report demonstrates that the acute phase induction of hepatic ST6Gal I by IL-6 is through the upregulation of the liver-restricted, Exon H-containing P1 transcript. Though the role of the hepatic reaction is far from clear, it is generally viewed as a systemic response to maintain stasis and to limit inflammation at the site of trauma. The role of ST6Gal I and its sialylated catalytic products in this process is not know. However, given the recent appreciation for cell surface molecules exhibiting lectin-like activity toward sialic acid-containing ligands, the possibilities are tantalizing.
Materials and methods
Turpentine injection of wt and IL-6 deficient mice C57BL6/J wt and C57BL6/J / 129/J IL-6 deficient mice were injected subcutaneously with 25 µl of turpentine. Two animals were sacrificed at each 0, 0.5, 1.0, 2.0, 3.0, 4.0, 8.0, and 24 h time-points postinjection. IL-6 deficient animals, originally described by Kopf et al., 1979 (Kopf et al., 1994 , were a generous gift from Dr. Heinz Bauman, Roswell Park Cancer Institute.
Northern analysis
Total RNA was prepared from mouse liver using guanidine isothiocyanate method (Chirgwin et al., 1979) . Four micrograms of each total RNA were separated on formaldehyde agarose gels (Boedtker, 1971) , and transferred onto nylon filter (Zetabind, Cunno Inc., Meriden, CT). The filters were then hybridized with the 0.75 kb exon II containing dsDNA probe or a TPI (triose phosphate isomerase) dsDNA probe, both labeled with α-32 P (Amersham) using random priming. TPI, a housekeeping gene, was monitored to ensure equal loading of RNA samples and to verify the integrity of the RNA.
5′-RACE analysis
All RNA samples used for 5′-RACE analysis were routinely checked by agarose gels to ensure the integrity of the RNA. The 5′-Amplifinder RACE kit from Clontech was used. Twenty micrograms of total RNA from mouse liver was annealed to the primer mST1-P1 (5′-GATGATGGCAAACAGGAGAA-3′) and reverse transcribed. MST1-P1 is complementary to a region in Exon II, such that authentic reverse transcription events of ST6Gal I mRNA must span at least the Exon I-Exon II boundary. The resultant cDNA was ligated to the anchor primer as per instructions and subjected to PCR using the "touchdown" program recommended by Clontech, using the anchor primer AP1 (5′-CCATCCTAATACGACTCACTATAGGGC-3′) and the ST6Gal I Exon I antisense primer md11 (5′-CTGCTTCTGGCTA-ATCTTCTGGGGTTGG-3′). PCR amplification of ST6Gal I sequence from contaminating genomic DNA is not possible since ST6Gal I gene does not contain sequences that will specifically anneal the anchor primer. Touchdown PCR parameters are 94_C for 1 min, 5 cycles of 94_C for 30 sec, 72_C for 4 min, 5 cycles of 94_C for 30 sec, 70_C for 4 min and finally 25 cycles of 94_C for 20 sec, 68_C for 4 min. The PCR products were cloned into the plasmid vector pCRII (Invitrogen, San Diego, CA) and sequenced where appropriate.
Southern analysis of 5′-RACE products
5′-RACE, PCR amplified (AP1/md11), DNA, derived from total liver RNA from the 0 and 24 h time points of both wt and IL-6 deficient mice, were run on a 3.0% agarose gel containing 5 µg/ml ethidium bromide, photographed, and Southern blotted to a positively charged nylon filter (Zetabind, Cunno Inc., Meriden, CT) using 0.4 M NaOH overnight. The filter was then neutralized in 2× SSC for 10 min, air dried for 30 min, and then vacuum baked at 80_C for 1 h. The blot was then hybridized with the 1.2 kb, Exon H-containing, dsDNA probe labeled with α-32 P (Amersham) using random priming.
Generation of hybridization probes
The 0.75 kb ST6Gal I exon II was isolated from a cloned insert of 5.5 kb derived from lambda clone λMGST1, and the 1.2 kb Exon H probe was isolated from a cloned insert derived from lambda clone λ0501 as described previously (Hu et al., 1997) . ST3Gal I probe is a 250 bp PCR fragment partially spanning the first coding exon, derived from mouse genomic DNA. The ST3Gal III probe is a 822 bp rat cDNA. The ST3Gal IV was a 486 bp PCR fragment, derived from human genomic DNA, spanning the first coding exon.
